tellurium has been researched along with Breast-Neoplasms* in 26 studies
26 other study(ies) available for tellurium and Breast-Neoplasms
Article | Year |
---|---|
Evaluation and comparison of a CdTe based photon counting detector with an energy integrating detector for X-ray phase sensitive imaging of breast cancer.
To compare imaging performance of a cadmium telluride (CdTe) based photon counting detector (PCD) with a CMOS based energy integrating detector (EID) for potential phase sensitive imaging of breast cancer.. A high energy inline phase sensitive imaging prototype consisting of a microfocus X-ray source with geometric magnification of 2 was employed. The pixel pitch of the PCD was 55μm, while 50μm for EID. The spatial resolution was quantitatively and qualitatively assessed through modulation transfer function (MTF) and bar pattern images. The edge enhancement visibility was assessed by measuring edge enhancement index (EEI) using the acrylic edge acquired images. A contrast detail (CD) phantom was utilized to compare detectability of simulated tumors, while an American College of Radiology (ACR) accredited phantom for mammography was used to compare detection of simulated calcification clusters. A custom-built phantom was employed to compare detection of fibrous structures. The PCD images were acquired at equal, and 30% less mean glandular dose (MGD) levels as of EID images. Observer studies along with contrast to noise ratio (CNR) and signal to noise ratio (SNR) analyses were performed for comparison of two detection systems.. MTF curves and bar pattern images revealed an improvement of about 40% in the cutoff resolution with the PCD. The excellent spatial resolution offered by PCD system complemented superior detection of the diffraction fringes at boundaries of the acrylic edge and resulted in an EEI value of 3.64 as compared to 1.44 produced with EID image. At equal MGD levels (standard dose), observer studies along with CNR and SNR analyses revealed a substantial improvement of PCD acquired images in detection of simulated tumors, calcification clusters, and fibrous structures. At 30% less MGD, PCD images preserved image quality to yield equivalent (slightly better) detection as compared to the standard dose EID images.. CdTe-based PCDs are technically feasible to image breast abnormalities (low/high contrast structures) at low radiation dose levels using the high energy inline phase sensitive imaging technique. Topics: Breast Neoplasms; Cadmium Compounds; Female; Humans; Phantoms, Imaging; Photons; Quantum Dots; Tellurium; X-Rays | 2022 |
Identification and elimination of cancer cells by folate-conjugated CdTe/CdS Quantum Dots Chiral Nano-Sensors.
The specific identification and elimination of cancer cells has been a great challenge in the past few decades. In this study, the circular dichroism (CD) of cells was measured by a self-designed special system through the folate-conjugated chiral nano-sensor. A novel method was established to recognize cancer cells from normal cells according to the chirality of cells based on their CD signals. After a period of interaction between the nano-sensor and cells, the sharp weakening of CD signals was induced in cancer cells but normal cells remained unchanged. The biocompatibility of the nano-sensor was evaluated and the result showed that it exhibited significant cytotoxic activity against cancer cells while no obvious damage on normal cells. Notably, the research indicated that the nano-sensor may selectively cause apoptosis in cancer cells, and thus, have the potential to act as an antitumor agent. Topics: Apoptosis; Breast Neoplasms; Cadmium Compounds; Cell Line, Tumor; Circular Dichroism; Female; Folic Acid; Humans; Neoplasms; Quantum Dots; Sulfides; Tellurium | 2021 |
Ultrasmall Ag
With the fast development of nanomedicine, the imaging-guided and photo-induced cancer monotherapies can efficiently eliminate tumor lesions, which are strongly dependent on the construction of versatile theranostic nanoplatforms. Among diverse photo-converting nanoplatforms, silver chalcogenide nanoparticles feature high biocompatibility, narrow band gaps, and tunable optical properties, yet Ag Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Hyperthermia, Induced; Infrared Rays; Mice; Particle Size; Photochemical Processes; Phototherapy; Quantum Dots; Silver; Surface Properties; Tellurium; Tomography, X-Ray Computed | 2020 |
Synthesis of novel tellurides bearing benzensulfonamide moiety as carbonic anhydrase inhibitors with antitumor activity.
We have synthetized a novel series of β-hydroxy tellurides bearing the benzenesulfonamide group as potent inhibitors of carbonic anhydrase enzymes. In a one pot procedure, we discovered both the ring opening reaction of the three-membered ring and the cleavage of the sulfonamide protecting moiety at the same time. Moreover, the first X-ray co-crystallographic structure of a β-hydroxy telluride derivative with hCA II is reported. The potent effects of these compounds against the tumor-associated hCA IX with low nanomolar constant inhibition values give the possibility to evaluate their activity in vitro using a breast cancer cell line (MDA-MB-231). Compounds 7e and 7g induced significant toxic effects against tumor cells after 48 h incubation in normoxic conditions killing over 50% of tumor cells at 3 μM, but their efficacy decreased in hypoxic conditions reaching the 50% of the tumor cell viability only at 30 μM. These unusual features make them interesting lead compounds to act as antitumor agents, not only as Carbonic Anhydrase IX inhibitors, but reasonably in different pathways, where hCA IX is not overexpressed. Topics: Antigens, Neoplasm; Antineoplastic Agents; Benzenesulfonamides; Breast Neoplasms; Carbonic Anhydrase II; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IX; Cell Line, Tumor; Crystallography, X-Ray; Female; Humans; Molecular Docking Simulation; Sulfonamides; Tellurium | 2019 |
Ultrasensitive electroluminescence biosensor for a breast cancer marker microRNA based on target cyclic regeneration and multi-labeled magnetized nanoparticles.
An electrochemiluminescent (ECL) biosensor is described for the determination of the breast cancer biomarker microRNA. The method is based on the amplification via target cyclic regeneration through a system of hairpin DNA probes, primers, and Klenow fragment of DNA polymerases combined with CdTe quantum dots (QDs) and gold nanoparticles. The assay is performed by exploiting the luminescence properties of CdTe-QDs and K Topics: Biomarkers, Tumor; Biosensing Techniques; Breast Neoplasms; Cadmium Compounds; DNA-Directed DNA Polymerase; Electrochemical Techniques; Female; Gold; Humans; Luminescent Measurements; Magnetite Nanoparticles; MicroRNAs; Particle Size; Quantum Dots; Surface Properties; Tellurium | 2019 |
The influence of anthropometric and basic circulatory variables on count rate in cadmium-zinc-telluride SPECT gated radionuclide angiography.
To determine the influence of weight, height, gender, age, heart rate, and blood pressure on count rate in cadmium-zinc-telluride single-photon emission computed tomography (CZT SPECT) gated radionuclide angiography.. A total of 1,065 eligible patients referred for routine assessment of left ventricular ejection fraction were registered from August 2015 to November 2016. Data were recorded on heart rate, systolic and diastolic blood pressure, age, gender, height, weight, and count rate. All radionuclide angiographies were performed on a dedicated cardiac CZT SPECT camera, GE Discovery 530c. A dose of 550 MBq. Count rate varied from 1.2 to 8.9 counts per second. All test variables were significantly associated with count rate. From the preliminary analysis, weight appeared as the main contributing factor for explaining the variations in count rate with and R. Patient height, weight, gender, and age have significant impact on count rate when performing CZT radionuclide angiography and may subsequently be used for individualized planning of tracer dosage. Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiography; Anthropometry; Blood Pressure; Breast Neoplasms; Cadmium; Cardiac-Gated Single-Photon Emission Computer-Assisted Tomography; Cardiomyopathies; Female; Heart Rate; Humans; Kidney Neoplasms; Liver Neoplasms; Lymphoma, Large B-Cell, Diffuse; Male; Melanoma; Middle Aged; Ovarian Neoplasms; Quality Control; Regression Analysis; Retrospective Studies; Tellurium; Young Adult; Zinc | 2019 |
Targeted imaging of breast cancer cells using two different kinds of aptamers -functionalized nanoparticles.
Breast cancer which is the most commonly diagnosed cancer among women; have been known as a serious threat for health and life around the world. So development of an approach for early-stage diagnosis of breast cancer is vital. In this study, we designed a double aptamer-nanoparticle conjugates-based (DANP) complex for specific detection and visualization of MCF-7 cells using Mucin 1 (MUC 1) aptamer-conjugated gold nanoparticles (MUC1 apt - GNPs) and adenosine triphosphate (ATP) aptamer-conjugated CdTe quantum dots (ATP apt-QDs). The ATP apt-QDs was attached onto MUC1 apt - GNPs surface through Van der Waals forces and electrostatic interactions between ATP aptamer and GNPs leading to the formation of DANP complex. Atomic force microscopy asserted DANP complex formation. The imaging process was based on the recognition of MUC1 protein on the surface of MCF-7 cells by MUC1 aptamer and specific internalization of DANP complex into target cells (MCF-7). Existence of abundant amounts of ATP in lysosome led to release of ATP apt-QDs from the MUC1 apt-GNPs surface resulting in strong fluorescence emission. The flow cytometry analysis and fluorescence microscopy confirmed significant internalization of DANP complex into MCF-7 cells (target) in comparison with CHO cells (non-target). Based on the obtained results, the DANP complex possesses high potency for efficient detection and monitoring of breast cancer cells (MCF-7). Topics: Animals; Aptamers, Nucleotide; Breast Neoplasms; Cadmium Compounds; Cell Line, Tumor; CHO Cells; Cricetulus; Female; Gold; Humans; MCF-7 Cells; Membrane Proteins; Metal Nanoparticles; Molecular Imaging; Mucin-1; Optical Imaging; Quantum Dots; Tellurium | 2019 |
Involvement of ABC transporters in the efflux and toxicity of MPA-COOH-CdTe quantum dots in human breast cancer SK-BR-3 cells.
This paper aimed to study the possible involvement of adenosine triphosphate-binding cassette (ABC) transporters in the detoxification of quantum dots (QDs) in human breast carcinoma (SK-BR-3) cells. The effects of QD sizes on such interactions were also evaluated. For this purpose, we used monodispersed MPA-COOH-CdTe QDs with different diameters (emission length at 560 and 625 nm, named as QD-560 and QD-625). Such QDs tended to accumulate in cells and cause significant toxicity. Using specific inhibitors of ABC transporters, the cellular accumulation and toxicity of QDs in SK-BR-3 cells were significantly affected. Moreover, treatment of QDs caused concentration- and time-dependent induction of ABC transporters. Furthermore, the induction effects of smaller QDs were found to be greater than larger ones at equivalent concentrations, suggesting a size-dependent recognition of substrates by ABC transporters. Overall, these results provided important support for the modulation of QDs toxicity by ABC transporters. Topics: ATP-Binding Cassette Transporters; Biological Transport; Breast Neoplasms; Cadmium Compounds; Cell Line, Tumor; Female; Humans; Quantum Dots; Tellurium | 2019 |
Bifunctional Tellurium Nanodots for Photo-Induced Synergistic Cancer Therapy.
Elemental tellurium (Te) nanoparticles are increasingly important in a variety of applications such as thermoelectricity, photoconductivity, and piezoelectricity. However, they have been explored with limited success in their biomedical use, and thus a tremendous challenge still exists in the exploration of Te nanoparticles that can treat tumors as an effective anticancer agent. Here, we introduce bifunctional Te nanodots with well-defined nanostructure as an effective anticancer agent for photo-induced synergistic cancer therapy with tumor ablation, which is accomplished using hollow albumin nanocages as a nanoreactor. Under near-infrared light irradiation, Te nanodots can produce effective photothermal conversion, as well as highly reactive oxygen species such as •O Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Drug Screening Assays, Antitumor; Metal Nanoparticles; Mice; Particle Size; Photochemical Processes; Photochemotherapy; Reactive Oxygen Species; Surface Properties; Tellurium | 2017 |
Dual-function fluorescent probe for cancer imaging and therapy.
To date, several fluorescent probes modified by a single targeting agent have been explored. However, studies on the preparation of dual-function quantum dot (QD) fluorescent probes with dual-targeting action and a therapeutic effect are rare. Here, a dual-targeting CdTe/CdS QD fluorescent probe with a bovine serum albumin-glycyrrhetinic acid conjugate and arginine-glycine-aspartic acid was successfully prepared that could induce the apoptosis of liver cancer cells and showed enhanced targeting in in vitro cell imaging. Therefore, the as-prepared fluorescent probe in this work is an efficient diagnostic tool for the simultaneous detection of liver cancer and breast cancer cells. Topics: Animals; Apoptosis; Breast Neoplasms; Cadmium Compounds; Cattle; Cell Survival; Cells, Cultured; Female; Fluorescence; Fluorescent Dyes; Glycyrrhetinic Acid; Humans; Liver Neoplasms; Oligopeptides; Quantum Dots; Serum Albumin, Bovine; Tellurium | 2016 |
Folate receptor-targeted multimodal polymersomes for delivery of quantum dots and doxorubicin to breast adenocarcinoma: In vitro and in vivo evaluation.
In this study, we report the design and delivery of tumor-targeted, quantum dot (QD) and doxorubicin (DOX)-encapsulated PEG-PLGA nanopolymersomes (NPs) for the imaging and chemotherapy of breast cancer. To achieve active cancer targeting, QD and DOX-encapsulated NPs were conjugated with folate for folate-binding protein receptor-guided delivery, which overexpressed in many cancer cells. Hydrophobic DOX and hydrophilic MSA-capped QD were encapsulated in the bilayer and core of the PEG-PLGA nanopolymersomes, respectively. The data show that the formulated NPs sustained DOX release for a period of 12 days. Fluorescence microscopy and MTT assay demonstrated that the developed folate-targeted DOX-QD NPs had higher cytotoxicity than non-targeted NPs and the free form of the drug; moreover, they preferentially accumulated in 4T1 and MCF-7 cells in vitro. In vivo experiments including whole organ tissue-homogenate analysis and organ fluorescence microscopy imaging of BALB/c mice bearing 4T1 breast adenocarcinoma showed that the folate receptor-targeted QD encapsulated NPs accumulate at tumor sites 6h following intravenous injection. Acute toxicity studies of the prepared targeted QD-loaded NPs showed no evidence of long-term harmful histopathological and physiological effects on the treated animals. The in vivo tumor inhibitory effect of folic acid (FA)-QD-DOX NPs demonstrated an augmented therapeutic efficacy of targeted formulation over the non-targeted and free drug. The data obtained illustrate a high potential of the prepared targeted theranostic nanoplatform in the treatment and imaging of breast cancer. This study may open new directions for preparation of QD-based theranostic polymersomes for clinical application. Topics: Adenocarcinoma; Animals; Antibiotics, Antineoplastic; Breast Neoplasms; Cadmium Compounds; Cell Line, Tumor; Cell Survival; Doxorubicin; Drug Delivery Systems; Drug Liberation; Folic Acid; Folic Acid Transporters; Humans; Mice; Mice, Inbred BALB C; Microscopy, Electron, Transmission; NIH 3T3 Cells; Polyesters; Polyethylene Glycols; Quantum Dots; Tellurium; Tumor Burden | 2016 |
Imaging performance of phase-contrast breast computed tomography with synchrotron radiation and a CdTe photon-counting detector.
Within the SYRMA-CT collaboration based at the ELETTRA synchrotron radiation (SR) facility the authors investigated the imaging performance of the phase-contrast computed tomography (CT) system dedicated to monochromatic in vivo 3D imaging of the female breast, for breast cancer diagnosis.. Test objects were imaged at 38keV using monochromatic SR and a high-resolution CdTe photon-counting detector. Signal and noise performance were evaluated using modulation transfer function (MTF) and noise power spectrum. The analysis was performed on the images obtained with the application of a phase retrieval algorithm as well as on those obtained without phase retrieval. The contrast to noise ratio (CNR) and the capability of detecting test microcalcification clusters and soft masses were investigated.. For a voxel size of (60μm)(3), images without phase retrieval showed higher spatial resolution (6.7mm(-1) at 10% MTF) than corresponding images with phase retrieval (2.5mm(-1)). Phase retrieval produced a reduction of the noise level and an increase of the CNR by more than one order of magnitude, compared to raw phase-contrast images. Microcalcifications with a diameter down to 130μm could be detected in both types of images.. The investigation on test objects indicates that breast CT with a monochromatic SR source is technically feasible in terms of spatial resolution, image noise and contrast, for in vivo 3D imaging with a dose comparable to that of two-view mammography. Images obtained with the phase retrieval algorithm showed the best performance in the trade-off between spatial resolution and image noise. Topics: Algorithms; Breast; Breast Neoplasms; Cadmium Compounds; Calcinosis; Contrast Media; Equipment Design; Female; Humans; Mammography; Microscopy, Phase-Contrast; Photons; Radiation Dosage; Radiographic Image Interpretation, Computer-Assisted; Signal-To-Noise Ratio; Synchrotrons; Tellurium; Tomography, X-Ray Computed | 2016 |
Cancer Cell Targeting Using Folic Acid/Anti-HER2 Antibody Conjugated Fluorescent CdSe/CdS/ZnS-Mercaptopropionic Acid and CdTe-Mercaptosuccinic Acid Quantum Dots.
CdSe/CdS/ZnS and CdTe quantum dots (QDs) were synthesized by successive ion layer adsorption and reaction (SILAR) technique and direct aqueous synthesis respectively using thiol stabilizers. Synthesized CdSe/CdS/ZnS and CdTe QDs stabilized with 3-mercaptopropionic acid (MPA) and mercaptosuccinic acid (MSA) were used as fluorescent labels after conjugation with folic acid (FA) and anti-HER2 antibodies. Photoluminescence quantum yield of folated CdSe/CdS/ZnS-MPA and CdTe-MSA QDs was 59% and 77% than that of non-folated hydrophilic QDs. The folate receptor-mediated delivery of folic acid-conjugated CdTe-MSA and CdSe/CdS/ZnS-MPA QDs showed higher cellular internalization as observed by confocal laser scanning microscopic studies. Folated and non-folated CdTe-MSA QDs were highly toxic and exhibited only 10% cell viability as compared to > 80% cell viability with CdSe/CdS/ZnS-MPA QDs over the concentration ranging from 3.38 to 50 pmoles. Immunohistochemistry (IHC) results of human breast cancer tissue samples showed positive results with anti-HER2 antibody conjugated CdSe/CdS/ZnS-MPA QDs with better sensitivity and specificity as compared to conventional IHC analysis using diaminobenzedene staining. Topics: 3-Mercaptopropionic Acid; Animals; Antibodies, Neoplasm; Breast Neoplasms; Cadmium Compounds; Drug Delivery Systems; Female; Folic Acid; Humans; Mice; Mice, Inbred BALB C; Quantum Dots; Receptor, ErbB-2; Selenium Compounds; Succinates; Sulfides; Tellurium; Zinc Compounds | 2016 |
Multifunctional Cu
Hypermethylated cancer populations are hard to treat due to their enhanced chemo-resistance, characterized by aberrant methylated DNA subunits. Herein, we report on invoking response from such a cancer lineage to chemotherapy utilizing multifunctional copper telluride (Cu Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Contrast Media; Copper; Drug Carriers; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Humans; Hyperthermia, Induced; Models, Biological; Nanostructures; Photoacoustic Techniques; Photochemotherapy; Photosensitizing Agents; Tellurium; Theranostic Nanomedicine; X-Rays | 2016 |
Characterization and cancer cell targeted imaging properties of human antivascular endothelial growth factor monoclonal antibody conjugated CdTe/ZnS quantum dots.
High luminescence quantum yield water-soluble CdTe/ZnS core/shell quantum dots (QDs) stabilized with thioglycolic acid were synthesized. QDs were chemically coupled to fully humanized antivascular endothelial growth factor165 monoclonal antibodies to produce fluorescent probes. These probes can be used to assay the biological affinity of the antibody. The properties of QDs conjugated to an antibody were characterized by ultraviolet and visible spectrophotometry, fluorescent spectrophotometry, sodium dodecyl sulfate-polyacrylamide gel electrophoresis, transmission electron microscopy and fluorescence microscopy. Cell-targeted imaging was performed in human breast cancer cell lines. The cytotoxicity of bare QDs and fluorescent probes was evaluated in the MCF-7 cells with an MTT viability assay. The results proved that CdTe/ZnS QD-monoclonal antibody nanoprobes had been successfully prepared with excellent spectral properties in target detections. Surface modification by ZnS shell could mitigate the cytotoxicity of cadmium-based QDs. The therapeutic effects of antivascular endothelial growth factor antibodies towards cultured human cancer cells were confirmed by MTT assay. Topics: Antibodies, Monoclonal; Antineoplastic Agents; Breast Neoplasms; Cadmium; Cell Line, Tumor; Cell Survival; Diagnostic Imaging; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Female; Fluorescent Dyes; Humans; MCF-7 Cells; Microscopy, Electron, Transmission; Microscopy, Fluorescence; Quantum Dots; Selenium Compounds; Spectrometry, Fluorescence; Tellurium; Vascular Endothelial Growth Factor A; Zinc Compounds | 2014 |
Paclitaxel loaded fibrinogen coated CdTe/ZnTe core shell nanoparticles for targeted imaging and drug delivery to breast cancer cells.
The study aims at the targeted imaging using CdTe/ZnTe core shell QDs and delivery of paclitaxel (PTX) loaded fibrinogen coated yellow-QDs (PTX-fib-yellow-QDs) towards breast cancer cells via the alpha5Beta1-integrins. We developed fibrinogen coated different sized CdTe/ZnTe core shell quantum dots of 2-10 nm size, which have been prepared by one-pot aqueous-phase approach. The fib-coated-QDs (fib-coated-QDs) and PTX-fib-yellow-QDs were prepared by two-step coacervation technique using CaCl2 as cross-linker. Particle size of fib-coated-QDs was in between 60-220 nm while PTX-fib-yellow-QDs showed 180 +/- 40 nm. The MTT assay confirmed cytocompatibility of fib-coated-QDs on L929 and MCF-7 than bare QDs, whereas significant toxicity toward MCF-7 by PTX-fib-yellow-QDs was observed. The hemocompatible fib-coated-QDs showed enhanced localization and retention toward alpha5beta1-integrins +ve MCF-7 compared to alpha5beta1-integrins -ve L929 cells. The specific binding of fib-coated-yellow-QDs was further confirmed with alpha5beta1-integrins +ve HeLa and alpha5/beta1-integrins -ve HT29 cells. Cellular uptake studies revealed localization of PTX-fib-coated-yellow-QDs inside MCF-7 cells compared to the normal L929 cells. These results indicated that fib-coated-QDs could be used for targeted imaging and as a suitable "nanocarrier" aiming breast cancer cells. Topics: Animals; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cadmium Compounds; Cell Line, Tumor; Diffusion; Female; Fibrinogen; Humans; Mice; Nanocapsules; Paclitaxel; Tellurium; Zinc | 2013 |
Proof of concept for low-dose molecular breast imaging with a dual-head CZT gamma camera. Part II. Evaluation in patients.
Molecular breast imaging (MBI) has shown promise as an adjunct screening technique to mammography for women with dense breasts. The demonstration of reliable lesion detection with MBI performed at low administered doses of Tc-99 m sestamibi, comparable in effective radiation dose to screening mammography, is essential to adoption of MBI for screening. The concept of performing low-dose MBI with dual-head cadmium zinc telluride (CZT) gamma cameras has been investigated in phantoms in Part I. In this work, the objectives were to evaluate the impact of the count sensitivity improvement methods on image quality in patient MBI exams and to determine if adequate lesion detection could be achieved at reduced doses.. Following the implementation of two count sensitivity improvement methods, registered collimation optimized for near-field imaging and energy acceptance window optimized for CZT, MBI exams were performed in the course of clinical care. Clinical image count density (counts/cm(2)) was compared between standard MBI [740 MBq (20 mCi) Tc-99 m sestamibi, standard collimation, standard energy window] and low-dose MBI [296 MBq (8 mCi) Tc-99 m sestamibi, optimized collimation, wide energy window] in a cohort of 50 patients who had both types of MBI exams performed. Lesion detection at low doses was evaluated in a separate cohort of 32 patients, in which low-dose MBI was performed following 296 MBq injection and acquired in dynamic mode, allowing the generation of images acquired for 2.5, 5, 7.5, and 10 min/breast view with proportionately reduced count densities. Diagnostic accuracy at each count density level was compared and kappa statistic was used to assess intrareader agreement between 10 min acquisitions and those at shorter acquisition durations.. In patient studies, low-dose MBI performed with 296 MBq Tc-99 m sestamibi and new optimal collimation/wide energy window resulted in an average relative gain in count density of 4.2 ± 1.3 compared to standard MBI performed with 740 MBq. Interpretation of low-dose 296 MBq images with count densities corresponding to acquisitions of 2.5, 5, 7.5, and 10 min/view and median lesion size of 1.4 cm resulted in similar diagnostic accuracy across count densities and substantial to near-perfect intrareader agreement between full 10 min-views and lower count density views.. Review of patient studies showed that registered optimized collimation and wide energy window resulted in a substantial gain in count sensitivity as previously indicated by phantom results. This proof of concept work indicates that MBI performed at administered doses of 296 MBq Tc-99 m sestamibi with the applied count sensitivity improvements permits the detection of small breast lesions in patients. Findings suggest that further reductions in acquisition duration or administered dose may be achievable. Topics: Breast; Breast Neoplasms; Cadmium; Female; Gamma Cameras; Humans; Radiation Dosage; Radionuclide Imaging; Retrospective Studies; Sensitivity and Specificity; Tellurium; Tumor Burden; Zinc | 2012 |
Synthesis of mercaptosuccinic acid/MercaptoPolyhedral oligomeric silsesquioxane coated cadmium telluride quantum dots in cell labeling applications.
An aqueous synthesis method to obtain highly luminescent cadmium telluride nanocrystals is described. We have shown water-soluble semi-conductor quantum dots with high photoluminescence quantum yield have great potential for biological applications. The spectral properties of these nanocrystals can be easily tuned according to their particle size to yield multicolours simultaneously by a single excitation light source. A stable precursor material sodium tellurite is utilised instead of the traditional oxygen sensitive NaHTe or H2Te as Te source. We have introduced mercaptosuccinic acid and propylisobutyl polyhedral oligomeric silsesquioxane nanoparticles as novel capping agents to stabilize the nanocrystals, synthesized in borate-citrate buffering system. Inclusion of propylisobutyl polyhedral oligomeric silsesquioxane nanoparticles in the capping procedure showed enhanced stability and biocompatibility. The presence of mercaptosuccinic acid/propylisobutyl polyhedral oligomeric silsesquioxane coatings was confirmed by Fourier Transform Infrared spectroscopy and average sizes of 2-5 nm by transmission electron microscopy measurements. The functionalized and targeted quantum dots detected cancer cell death on exposure to some anticancer drugs. Studies have indicated that apoptotic cells can activate signaling pathways in dendritic cells via ligation of surface receptors. Cells treated with specific class of pro-apototic drug such as anthracyclines mount an anti-tumour immune response when introduced into mice. Apoptotic cells may be immunogenic or non-immunogenic depending on the presence of calreticulin on the plasma membrane of dying tumour cells. Here the confocal microscopy showed localization of conjugated mercaptosuccinic acid/propylisobutyl polyhedral oligomeric silsesquioxane cadmium telluride quantum dots on MCF-7 cells when exposed to cadmium ions at 50 microM, compared to coated quantum dots. We have used cadmium ions as a model drug as certain anticancer drugs (anthracyclines) induce translocation of calreticulin to the cell membrane, an indicator of apoptosis. Antibodies generated against a peptide to human calreticulin and conjugated to quantum dots detected the protein on cell membrane of stimulated cells were visualized by confocal microscopy. Stimulating natural immune response, against tumours has enormous potential to improve current regimens of cancer detection and therapy. Topics: Breast Neoplasms; Cadmium Compounds; Cell Line, Tumor; Humans; Microscopy, Fluorescence; Nanocapsules; Organosilicon Compounds; Quantum Dots; Staining and Labeling; Tellurium; Thiomalates | 2012 |
Feasibility study of a unilateral RF array coil for MR-scintimammography.
Despite its high sensitivity, the variable specificity of magnetic resonance imaging (MRI) in breast cancer diagnosis can lead to unnecessary biopsies and over-treatment. Scintimammography (SMM) could potentially supplement MRI to improve the diagnostic specificity. The synergistic combination of MRI and SMM (MRSMM) could result in both high sensitivity from MRI and high specificity from SMM. Development of such a dual-modality system requires the integration of a radio frequency (RF) coil and radiation detector in a strong magnetic field without significant mutual interference. In this study, we developed and tested a unilateral breast array coil specialized for MRSMM imaging. The electromagnetic field, specific absorption ratio and RF coil parameters with cadmium-zinc-telluride detectors encapsulated in specialized RF and gamma-ray shielding mounted within the RF coil were investigated through simulation and experimental measurements. Simultaneous MR and SMM images of a breast phantom were also acquired using the integrated MRSMM system. This work, we feel, represents an important step toward the fabrication of a working MRSMM system. Topics: Breast; Breast Neoplasms; Cadmium; Copper; Electromagnetic Fields; Equipment Design; Feasibility Studies; Female; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Mammography; Phantoms, Imaging; Tellurium; Zinc | 2011 |
[Detection of the expression of HER2 using CdTe/ZnSe core/shell quantum dots as fluorescence probe in breast cancer cells].
Topics: Breast Neoplasms; Cadmium Compounds; Cell Line, Tumor; Female; Humans; Quantum Dots; Receptor, ErbB-2; Selenium Compounds; Spectrometry, Fluorescence; Tellurium; Zinc Compounds | 2011 |
Aqueous synthesis and fluorescence-imaging application of CdTe/ZnSe core/shell quantum dots with high stability and low cytotoxicity.
CdTe/ZnSe core/shell quantum dots were directly synthesized in an aqueous condition by heating a mixed solution of ZnCI2, NaHSe and CdTe QDs in the presence of mercaptosuccinic acid as a stabilizer. By controlling the size and composition, the CdTe/ZnSe QDs with emission wavelength ranging from 540 to 630 nm, high quantum yield (44%) and narrow full width at half maximum (FWHM) could be obtained. Characterization results with HRTEM, XRD and EDX have shown that the synthesized CdTe/ZnSe QDs have good monodispersity and a nice crystal structure, and exhibited better stability and less cytotoxicity as compared with CdTe QDs. Furthermore, luminescent QD-IgG bioprobes were produced to detect the breast cancer marker Her2 on the surface of fixed MCF-7 cancer cells for their optical imaging. Topics: Breast Neoplasms; Cadmium Compounds; Cell Line, Tumor; Fluorescence; Humans; Microscopy, Electron, Transmission; Quantum Dots; Selenium Compounds; Tellurium; Water; X-Ray Diffraction; Zinc Compounds | 2010 |
Comparison of small field of view gamma camera systems for scintimammography.
To compare the performance characteristics of three compact gamma camera systems for scintimammography.. A multi-crystal NaI system (Dilon 6800), a multicrystal CsI system (Digirad 2020tc Imager) and a prototype cadmium zinc telluride (CZT) detector were evaluated using a breast phantom with simulated tumours of 1.8-9.8 mm in diameter and a tumour to background ratio of 5.6 : 1. A conventional Anger-based gamma camera was also evaluated for comparative purposes.. The conventional gamma camera had the highest intrinsic sensitivity of the four systems and utilized the highest resolution collimator. However, the prototype CZT and the CsI systems yielded the best spatial resolution over the range 0-5 cm from the collimator face and better visualized small (5-7 mm) tumours.. In addition to the advantage of close proximity to the breast, two of the three compact detectors offered superior performance to a conventional gamma camera for scintimammography. Topics: Breast; Breast Neoplasms; Cadmium; Cesium; Female; Gamma Cameras; Humans; Iodides; Mammography; Phantoms, Imaging; Radionuclide Imaging; Sensitivity and Specificity; Sodium Iodide; Tellurium; Zinc | 2005 |
Evaluation of fully 3-D emission mammotomography with a compact cadmium zinc telluride detector.
A compact, dedicated cadmium zinc telluride (CZT) gamma camera coupled with a fully three-dimensional (3-D) acquisition system may serve as a secondary diagnostic tool for volumetric molecular imaging of breast cancers, particularly in cases when mammographic findings are inconclusive. The developed emission mammotomography system comprises a medium field-of-view, quantized CZT detector and 3-D positioning gantry. The intrinsic energy resolution, sensitivity and spatial resolution of the detector are evaluated with Tc-99m (140 keV) filled flood sources, capillary line sources, and a 3-D frequency-resolution phantom. To mimic realistic human pendant, uncompressed breast imaging, two different phantom shapes of an average sized breast, and three different lesion diameters are imaged to evaluate the system for 3-D mammotomography. Acquisition orbits not possible with conventional emission, or transmission, systems are designed to optimize the viewable breast volume while improving sampling of the breast and anterior chest wall. Complications in camera positioning about the patient necessitate a compromise in these two orbit design criteria. Image quality is evaluated with signal-to-noise ratios and contrasts of the lesions, both with and without additional torso phantom background. Reconstructed results indicate that 3-D mammotomography, incorporating a compact CZT detector, is a promising, dedicated breast imaging technique for visualization of tumors < 1 cm in diameter. Additionally, there are no outstanding trajectories that consistently yield optimized quantitative lesion imaging parameters. Qualitatively, imaging breasts with realistic torso backgrounds (out-of-field activity) substantially alters image characteristics and breast morphology unless orbits which improve sampling are utilized. In practice, the sampling requirement may be less strict than initially anticipated. Topics: Breast Neoplasms; Cadmium Compounds; Equipment Design; Equipment Failure Analysis; Gamma Cameras; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Mammography; Miniaturization; Phantoms, Imaging; Reproducibility of Results; Sensitivity and Specificity; Tellurium; Tomography; Tomography, Emission-Computed, Single-Photon; Transducers; Zinc Compounds | 2005 |
Magnetic targeting and cellular uptake of polymer microcapsules simultaneously functionalized with magnetic and luminescent nanocrystals.
By using a flow channel system for modeling the bloodstream in the circulatory system and by locally creating a magnetic field gradient caused by a permanent magnet, we demonstrate specific trapping of polymer capsules simultaneously functionalized with two types of nanoparticles--magnetic and luminescent nanocrystals. In the regions where the capsules were trapped by the magnetic field, drastically increased uptake of capsules by cells has been observed. The uptake of capsules by cells could be conveniently monitored with a fluorescence microscope by the luminescence of CdTe nanocrystals that had been embedded into the shells of the capsules. Our experiments envisage the feasibility of magnetic targeting of polymer capsules loaded by pharmaceutical agents to pathogenic parts of a tissue. Topics: Breast Neoplasms; Cadmium Compounds; Capsules; Cell Line, Tumor; Drug Delivery Systems; Female; Humans; Luminescence; Magnetics; Models, Biological; Nanostructures; Polymers; Tellurium | 2005 |
Thioredoxin reductase and cancer cell growth inhibition by organotellurium antioxidants.
Thioredoxin (Trx) expression is increased in several human primary cancers and the Trx/Trx reductase (TrxR) system therefore provides an attractive target for cancer drug development. Novel organotellurium antioxidants, especially a primitive analog of vitamin E (compound 1d) and compounds 7, 9 and 10--all carrying highly functionalized 4-(dialkylamino)phenyltelluro groups to secure high antioxidative capacity--were found to inhibit TrxR with IC50 values in the low micromolar range. Whereas antioxidant 1d also inhibited the growth of MCF-7 human breast cancer cells in culture at a similar level (IC50 = 1.8 microM), the other TrxR inhibitors were inactive in concentrations below about 10 M. Topics: Antioxidants; Breast Neoplasms; Cell Division; Cell Survival; Enzyme Inhibitors; Humans; Organometallic Compounds; Oxidation-Reduction; Tellurium; Thioredoxin-Disulfide Reductase; Thioredoxins; Tumor Cells, Cultured | 2003 |
Evaluation of a small cadmium zinc telluride detector for scintimammography.
The purpose of this study was to evaluate a small semiconductor-based gamma camera that may have applications in scintimammography.. A small cadmium zinc telluride (CZT) detector was evaluated. The detector had a field of view of 20 x 20 cm with detector elements of 2.5 x 2.5 mm in size. Both short-bore (35 mm) and long-bore (50 mm) collimators, matched to the geometry of the detector elements, were evaluated. The imaging performance of the CZT detector was compared with that of a conventional gamma camera equipped with all-purpose and ultra-high-resolution collimators. The performance of both systems with respect to breast imaging was evaluated using a water tank containing small glass spheres, 1.8-9.8 mm in diameter. The effects of variations in breast thickness, tumor depth, and tumor-to-background ratio were all simulated in this phantom model. Total counts per image were adjusted to approximate the count density observed in clinical scintimammographic studies.. Sensitivity of the CZT detector was 76% that of the equivalent NaI system. The system demonstrated excellent integral uniformity. The energy resolution of the CZT system was 6.5% for (99m)Tc. Spatial resolution with the long-bore collimator was superior to that of a conventional large field-of -view gamma camera equipped with an ultra-high- resolution collimator, over the range 0-6 cm from the collimator face. A blinded review of breast phantom images showed that small spheres (< or =7 mm in diameter) were better seen and had a better tumor-to-background ratio with the CZT system than with the conventional gamma camera.. A small CZT detector offers superior performance to a conventional gamma camera and should permit reliable detection of breast tumors <1 cm in size. Topics: Breast; Breast Neoplasms; Cadmium Compounds; Carcinoma, Ductal, Breast; Equipment Design; Gamma Cameras; Humans; Phantoms, Imaging; Quality Control; Radiometry; Radionuclide Imaging; Reproducibility of Results; Sensitivity and Specificity; Tellurium; Transducers; Zinc | 2003 |